Ilex Capital Partners (Uk) LLP Bio Rad Laboratories, Inc. Transaction History
Ilex Capital Partners (Uk) LLP
- $2.45 Trillion
- Q1 2025
A detailed history of Ilex Capital Partners (Uk) LLP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Ilex Capital Partners (Uk) LLP holds 6,395 shares of BIO stock, worth $1.43 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,395Holding current value
$1.43 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
462Shares Held
18.9MCall Options Held
12.7KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA1.91MShares$428 Million0.01% of portfolio
-
First Eagle Investment Management, LLC1.57MShares$350 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$347 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$204 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$196 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $5.51B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...